Peter B. Berger

43.7k total citations · 7 hit papers
360 papers, 22.6k citations indexed

About

Peter B. Berger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter B. Berger has authored 360 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Cardiology and Cardiovascular Medicine, 203 papers in Surgery and 64 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter B. Berger's work include Acute Myocardial Infarction Research (175 papers), Coronary Interventions and Diagnostics (160 papers) and Antiplatelet Therapy and Cardiovascular Diseases (120 papers). Peter B. Berger is often cited by papers focused on Acute Myocardial Infarction Research (175 papers), Coronary Interventions and Diagnostics (160 papers) and Antiplatelet Therapy and Cardiovascular Diseases (120 papers). Peter B. Berger collaborates with scholars based in United States, Germany and Canada. Peter B. Berger's co-authors include Eric J. Topol, David R. Holmes, Steven R. Steinhubl, Malcolm R. Bell, Ryan J. Lennon, Deepak L. Bhatt, Charanjit S. Rihal, Edward T.A. Fry, Charles Wilmer and Augustin DeLago and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter B. Berger

349 papers receiving 21.6k citations

Hit Papers

Early and Sustained Dual Oral Antiplatelet Therapy Follow... 2002 2026 2010 2018 2002 2002 2009 2002 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
    2002 2.2k citations Peter B. Berger, Eric J. Topol et al. profile →
  2. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
    2002 1.3k citations Charanjit S. Rihal, Peter B. Berger et al. Circulation profile →
  3. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
    2009 780 citations Shanshan Chu, Richard C. Becker et al. Journal of Thrombosis and Haemostasis profile →
  4. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
    2002 603 citations Patricia J.M. Best, Ryan J. Lennon et al. Journal of the American College of Cardiology profile →
  5. Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
    2005 594 citations Joseph P. McConnell, Ryan J. Lennon et al. profile →
  6. Variability in platelet responsiveness to clopidogrel among 544 individuals
    2005 591 citations Peter B. Berger, Deepak L. Bhatt et al. Journal of the American College of Cardiology profile →
  7. The Perioperative Management of Antithrombotic Therapy
    2008 554 citations Peter B. Berger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter B. Berger United States 76 16.2k 10.5k 3.6k 3.5k 2.5k 360 22.6k
Robert M. Califf United States 81 23.3k 1.4× 6.9k 0.7× 6.0k 1.7× 1.6k 0.5× 2.8k 1.1× 284 28.8k
Debabrata Mukherjee United States 61 21.0k 1.3× 11.6k 1.1× 6.6k 1.8× 3.1k 0.9× 3.5k 1.4× 466 29.8k
Stefan James Sweden 76 21.6k 1.3× 11.5k 1.1× 4.2k 1.1× 4.1k 1.2× 1.9k 0.7× 496 26.7k
Marco Valgimigli Italy 80 23.4k 1.5× 15.2k 1.5× 7.0k 1.9× 3.7k 1.0× 3.9k 1.5× 526 29.6k
Gilles Montalescot France 80 23.1k 1.4× 12.3k 1.2× 3.3k 0.9× 5.8k 1.7× 2.7k 1.1× 553 28.8k
Karen S. Pieper United States 60 11.9k 0.7× 4.1k 0.4× 3.1k 0.9× 1.6k 0.5× 1.5k 0.6× 250 15.5k
Cindy L. Grines United States 83 23.1k 1.4× 17.5k 1.7× 10.7k 2.9× 2.5k 0.7× 3.0k 1.2× 493 31.9k
Ajay J. Kirtane United States 72 16.5k 1.0× 12.0k 1.1× 5.3k 1.4× 2.0k 0.6× 4.4k 1.8× 564 23.4k
Eric D. Peterson United States 69 19.6k 1.2× 7.3k 0.7× 5.9k 1.6× 2.2k 0.6× 1.1k 0.4× 226 24.1k
Derek P. Chew Australia 56 13.1k 0.8× 6.2k 0.6× 3.9k 1.1× 2.0k 0.6× 1.2k 0.5× 343 16.2k

Countries citing papers authored by Peter B. Berger

Since Specialization
Citations

This map shows the geographic impact of Peter B. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Berger more than expected).

Fields of papers citing papers by Peter B. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter B. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Berger. The network helps show where Peter B. Berger may publish in the future.

Co-authorship network of co-authors of Peter B. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Peter B. Berger. A scholar is included among the top collaborators of Peter B. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter B. Berger. Peter B. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannan, Edward L., Kimberly Cozzens, Linda S. Efferen, et al.. (2023). Impact of COVID‐19 on percutaneous coronary intervention utilization and mortality in New York. Catheterization and Cardiovascular Interventions. 101(6). 980–994. 2 indexed citations
2.
Hannan, Edward L., Kimberly Cozzens, Jacqueline Tamis‐Holland, et al.. (2023). Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality. Journal of the Society for Cardiovascular Angiography & Interventions. 2(2). 100559–100559. 2 indexed citations
3.
Hannan, Edward L., Zhong Ye, Kimberly Cozzens, et al.. (2023). New York Risk Model and Simplified Risk Score for In-Hospital/30-Day Mortality for Percutaneous Coronary Intervention. The American Journal of Cardiology. 206. 23–30. 2 indexed citations
4.
Hannan, Edward L., Zhong Ye, Kimberly Cozzens, et al.. (2023). Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease. JACC: Cardiovascular Interventions. 16(14). 1733–1742. 6 indexed citations
5.
Rafique, Asim, Tracy Y. Wang, Roxana Mehran, et al.. (2016). Optimal P2Y 12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 9(10). 1036–1046. 36 indexed citations
6.
Wang, Tracy Y., Timothy D. Henry, Mark B. Effron, et al.. (2015). Cluster-Randomized Clinical Trial Examining the Impact of Platelet Function Testing on Practice. Circulation Cardiovascular Interventions. 8(6). e001712–e001712. 13 indexed citations
7.
Chu, Shanshan, Richard C. Becker, Peter B. Berger, et al.. (2009). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. 8(1). 148–156. 780 indexed citations breakdown →
8.
Berger, Peter B.. (2007). Kurze Geschichte Österreichs im 20. Jahrhundert. WU Research. 2 indexed citations
9.
McConnell, Joseph P., Linnea M. Baudhuin, Peter B. Berger, et al.. (2007). Abstract 3608: Lipoprotein (a) Cholesterol, But Not Lp(a) Mass, Is An Independent Predictor Of Angiographic Coronary Artery Disease And Subsequent Cardiovascular Events In Patients Referred For Coronary Angiography.. Circulation. 116. 2 indexed citations
10.
Wiviott, Stephen D., Alan D. Michelson, Peter B. Berger, Norman E. Lepor, & Dean J. Kereiakes. (2006). Therapeutic goals for effective platelet inhibition: a consensus document.. PubMed. 7(4). 214–25. 5 indexed citations
11.
Alexander, John H., H. Yang, Richard C. Becker, et al.. (2005). First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. Journal of Thrombosis and Haemostasis. 3(3). 439–447. 40 indexed citations
12.
Best, Patricia J.M. & Peter B. Berger. (2004). Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease?. Catheterization and Cardiovascular Interventions. 61(4). 528–536. 2 indexed citations
13.
Best, Patricia J.M., Peter B. Berger, Barry R. Davis, et al.. (2004). Impact of mild or moderate chronic kidney disease on the frequency of restenosis. Journal of the American College of Cardiology. 44(9). 1786–1791. 58 indexed citations
14.
Powell, Brian D., Ryan J. Lennon, Amir Lerman, et al.. (2003). Association of body mass index with outcome after percutaneous coronary intervention. The American Journal of Cardiology. 91(4). 472–476. 76 indexed citations
15.
Singh, Mandeep, Peter B. Berger, Henry H. Ting, et al.. (2001). Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). The American Journal of Cardiology. 88(10). 1091–1096. 87 indexed citations
16.
Berger, Peter B.. (1998). Informatische Weltbilder - Professionelle Konzeptionen von Mathematik-Informatik-Lehrern.. 18. 41. 1 indexed citations
17.
Casserly, Ivan P., et al.. (1998). Usefulness of abciximab for treatment of early coronary artery stent thrombosis. The American Journal of Cardiology. 82(8). 981–985. 19 indexed citations
18.
Núñez, Boris D., et al.. (1996). Detailed intravascular ultrasound analysis after routine high pressure assisted intracoronary stent implantation. Journal of the American College of Cardiology. 27(2). 199–199. 1 indexed citations
19.
Hasdai, David, Kirk N. Garratt, David R. Holmes, et al.. (1996). Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. Journal of the American College of Cardiology. 28(2). 361–367. 68 indexed citations
20.
Holmes, David R., et al.. (1995). 715-1 Predictors of Mortality in Cardiogenic Shock: The GUSTO Experience. Journal of the American College of Cardiology. 25(2). 86A–86A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert M. Califf Breakdown of academic impact, for papers by Debabrata Mukherjee Breakdown of academic impact, for papers by Stefan James Breakdown of academic impact, for papers by Marco Valgimigli Breakdown of academic impact, for papers by Gilles Montalescot Breakdown of academic impact, for papers by Karen S. Pieper Breakdown of academic impact, for papers by Cindy L. Grines Breakdown of academic impact, for papers by Ajay J. Kirtane Breakdown of academic impact, for papers by Eric D. Peterson Breakdown of academic impact, for papers by Derek P. Chew
Rankless by CCL
2026